C. Rhizoma extract significantly reduced the IC50 value of fluorouracil (5-FU) in human CRC (HCT116) cells, and could act as a potential adjuvant agent against 5-FU-resistant CRCs by attenuating the expression of TS gene (Kang et al., 2021). This evidence concerns the gene TYMS and colorectal carcinoma.